Sue Griffin

670 total citations
14 papers, 522 citations indexed

About

Sue Griffin is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sue Griffin has authored 14 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 4 papers in Molecular Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sue Griffin's work include Alzheimer's disease research and treatments (7 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Tryptophan and brain disorders (2 papers). Sue Griffin is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Tryptophan and brain disorders (2 papers). Sue Griffin collaborates with scholars based in United States, United Kingdom and Japan. Sue Griffin's co-authors include D. Allan Butterfield, Giulio Maria Pasinetti, Gerald Münch, Michael W. Weiner, Domenico Praticò, Leon J. Thal, Dale Schenk, Douglas Galasko, Eric Siemers and Kejal Kantarci and has published in prestigious journals such as PLoS ONE, BMC Medicine and Oncotarget.

In The Last Decade

Sue Griffin

14 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sue Griffin United States	9	237	216	99	84	61	14	522
Rufina Leung United Kingdom	9	320 1.4×	286 1.3×	66 0.7×	112 1.3×	22 0.4×	10	788
Andreas Güntert United Kingdom	9	469 2.0×	296 1.4×	106 1.1×	70 0.8×	59 1.0×	10	650
Yanyan Kong China	12	178 0.8×	141 0.7×	33 0.3×	94 1.1×	39 0.6×	44	573
Sean A. McIsaac Canada	5	337 1.4×	299 1.4×	100 1.0×	213 2.5×	39 0.6×	6	798
Katsue Miyoshi Japan	8	288 1.2×	188 0.9×	28 0.3×	60 0.7×	87 1.4×	11	484
Ursula Mönning Germany	15	544 2.3×	460 2.1×	91 0.9×	62 0.7×	98 1.6×	20	841
Karl H. Weisgraber United States	8	417 1.8×	435 2.0×	42 0.4×	55 0.7×	55 0.9×	8	781
Payam Emami Khoonsari Sweden	17	195 0.8×	278 1.3×	75 0.8×	36 0.4×	62 1.0×	32	631
Kanta Yanagida Japan	14	282 1.2×	421 1.9×	48 0.5×	57 0.7×	118 1.9×	28	762
Kathleen M. Wood United States	13	310 1.3×	231 1.1×	48 0.5×	93 1.1×	267 4.4×	23	786

Countries citing papers authored by Sue Griffin

Since Specialization

Citations

This map shows the geographic impact of Sue Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Griffin more than expected).

Fields of papers citing papers by Sue Griffin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Griffin. The network helps show where Sue Griffin may publish in the future.

Co-authorship network of co-authors of Sue Griffin

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Griffin. A scholar is included among the top collaborators of Sue Griffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Griffin. Sue Griffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ayyadevara, Srinivas, Meenakshisundaram Balasubramaniam, B. Suresh Kuarm, et al.. (2023). Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan. Pharmaceuticals. 16(10). 1498–1498. 5 indexed citations

Balasubramaniam, Meenakshisundaram, Srinivas Ayyadevara, Narsimha Reddy Penthala, et al.. (2019). Aggregate Interactome Based on Protein Cross-linking Interfaces Predicts Drug Targets to Limit Aggregation in Neurodegenerative Diseases. iScience. 20. 248–264. 19 indexed citations

Ratti, Elena, Tina M. Olsson, Kumar Kandadi Muralidharan, et al.. (2018). P3‐033: RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED STUDY TO ASSESS TREATMENT OF BIIB092 IN SUBJECTS WITH EARLY ALZHEIMER'S DISEASE: TANGO PHASE 2 STUDY DESIGN. Alzheimer s & Dementia. 14(7S_Part_20). 1 indexed citations

Griffin, Sue, Meenakshisundaram Balasubramaniam, Chhanda Bose, et al.. (2018). P2‐181: IL‐1β INFLUENCES AUTOPHAGY BY MEDIATING UPREGULATION OF PARKIN AND PARKIN NEDDYLATION IN CELL CULTURE AND ANIMAL MODELS, AND MIMICS THE PATTERN SEEN IN AD BRAIN. Alzheimer s & Dementia. 14(7S_Part_13). 1 indexed citations

Hsu, Chia-Wen, Ruili Huang, Sue Griffin, et al.. (2016). Identification of approved and investigational drugs that inhibit hypoxia-inducible factor-1 signaling. Oncotarget. 7(7). 8172–8183. 18 indexed citations

Aboud, Orwa, Robert E. Mrak, Frederick A. Boop, & Sue Griffin. (2012). Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience. BMC Medicine. 10(1). 35–35. 24 indexed citations

Wallin, Jeffrey J., Jane Guan, Kyle A. Edgar, et al.. (2012). Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes. PLoS ONE. 7(5). e36402–e36402. 39 indexed citations

Foster, Rebecca R., Sue Griffin, Ruth E. Feltell, et al.. (2012). Multiple Metabolic Alterations Exist in Mutant PI3K Cancers, but Only Glucose Is Essential as a Nutrient Source. PLoS ONE. 7(9). e45061–e45061. 15 indexed citations

Thal, Dietmar Rudolf, Andreas Papassotiropoulos, Takaomi C. Saido, et al.. (2009). O2‐03‐03: Phenotypic and genetic subclassification of Alzheimer's disease. Alzheimer s & Dementia. 5(4S_Part_4). 20 indexed citations

10.

Thal, Leon J., Kejal Kantarci, Eric M. Reiman, et al.. (2006). The Role of Biomarkers in Clinical Trials for Alzheimer Disease. Alzheimer Disease & Associated Disorders. 20(1). 6–15. 179 indexed citations

11.

Butterfield, D. Allan, Sue Griffin, Gerald Münch, & Giulio Maria Pasinetti. (2002). Amyloid β-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. Journal of Alzheimer s Disease. 4(3). 193–201. 136 indexed citations

12.

MacGowan, S.H., Susan Love, Angela M. Hughes, et al.. (2001). The absence of HLA-DRB1*03 is a risk factor in Alzheimer's disease. ePrints Soton (University of Southampton). 1 indexed citations

13.

Lü, Xin, Stephen A. Burbidge, Sue Griffin, & Heather M. Smith. (1996). Discordance between accumulated p53 protein level and its transcriptional activity in response to u.v. radiation.. PubMed. 13(2). 413–8. 56 indexed citations

14.

Skinner, R.D., et al.. (1984). Interstitial nucleus of Cajal (INC) projections to the region of Probst's tract. Brain Research Bulletin. 13(5). 613–621. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact